Pictet Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,442
Closed -$49.8K 2133
2025
Q4
$49.8K Hold
12,442
﹤0.01% 2069
2025
Q3
$105K Hold
12,442
﹤0.01% 1975
2025
Q2
$140K Hold
12,442
﹤0.01% 1896
2025
Q1
$118K Hold
12,442
﹤0.01% 1899
2024
Q4
$140K Hold
12,442
﹤0.01% 1926
2024
Q3
$352K Hold
12,442
﹤0.01% 1515
2024
Q2
$238K Hold
12,442
﹤0.01% 1670
2024
Q1
$408K Hold
12,442
﹤0.01% 1387
2023
Q4
$411K Hold
12,442
﹤0.01% 1364
2023
Q3
$339K Buy
+12,442
New +$346K ﹤0.01% 1410

Other funds holding EVH

Pictet Asset Management's EVH Position: Q1 2026 in Review

Pictet Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 12,442 shares — an estimated $49.8K sold.

Pictet Asset Management first reported a position in EVH in Q3 2023 and held it in 10 quarters. The position peaked at $411K in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Pictet Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Pictet Asset Management sold 12,442 Evolent Health shares in Q1 2026, an estimated $49.8K.
  • Pictet Asset Management first reported a position in Evolent Health in Q3 2023 and held it in 10 quarters.
  • Pictet Asset Management's Evolent Health position peaked at $411K in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.